Morgan Stanley’s Marpai, Inc. Class A Common Stock MRAI Stock Holding History

Morgan Stanley’s Portfolio MRAI Stock Details MRAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-221	Closed	-$378	–	7855
2023 Q2	$378	Buy	+221	New	+$635	﹤0.01%	7402
2022 Q4	–	Sell	-5,001	Closed	-$21K	–	8015
2022 Q3	$21K	Sell	5,001 -3,525	-41%	-$13.5K	﹤0.01%	6782
2022 Q2	$33K	Sell	8,526 -28	-0.3%	-$149	﹤0.01%	6804
2022 Q1	$62K	Buy	+8,554	New	+$78.1K	﹤0.01%	6603

Other funds holding MRAI

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley's MRAI Position: Q3 2023 in Review

Morgan Stanley sold out of Marpai, Inc. Class A Common Stock (MRAI) in Q3 2023, closing a stake of 221 shares — an estimated $378 sold.

Morgan Stanley first reported a position in MRAI in Q1 2022 and held it in 4 quarters. The position peaked at $62K in Q1 2022. 8 funds tracked by Wall St. Rank hold MRAI as of Q3 2023.

Morgan Stanley reported no remaining Marpai, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Morgan Stanley sold 221 Marpai, Inc. Class A Common Stock shares in Q3 2023, an estimated $378.
Morgan Stanley first reported a position in Marpai, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Morgan Stanley's Marpai, Inc. Class A Common Stock position peaked at $62K in Q1 2022.
8 funds tracked by Wall St. Rank held Marpai, Inc. Class A Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.